Sutro Biopharma

About:

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

Website: http://www.sutrobio.com

Twitter/X: sutrobio

Top Investors: Eli Lilly, Merck, Samsara BioCapital, Citadel, Frazier Healthcare Partners

Description:

Sutro Biopharma is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.